Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 15.5a

Steroid Avoidance Rate at Discharge, 2000 to 2009

Recipients of Deceased Donor Livers

Discharge Regimen Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total Patients 3,621 3,748 4,060 4,434 4,882 5,022 5,318 5,265 5,169 5,284
Steroids Avoided 295 369 405 770 955 1,061 1,150 1,269 1,026 992
Rate 8.1% 9.8% 10.0% 17.4% 19.6% 21.1% 21.6% 24.1% 19.8% 18.8%
CyA Patients 226 117 97 76 58 65 34 42 35 45
Steroids Avoided 6 18 11 20 10 12 6 5 10 12
Rate 2.7% 15.4% 11.3% 26.3% 17.2% 18.5% 17.6% 11.9% 28.6% 26.7%
Tac Patients 1,196 1,338 1,646 1,639 1,759 1,691 1,371 1,246 1,009 1,004
Steroids Avoided 53 129 195 331 484 503 283 252 196 201
Rate 4.4% 9.6% 11.8% 20.2% 27.5% 29.7% 20.6% 20.2% 19.4% 20.0%
CyA+MMF Patients 258 212 186 179 194 188 218 226 233 232
Steroids Avoided 11 7 8 19 40 28 52 69 46 49
Rate 4.3% 3.3% 4.3% 10.6% 20.6% 14.9% 23.9% 30.5% 19.7% 21.1%
Tac+MMF Patients 1,204 1,433 1,595 2,049 2,333 2,703 3,296 3,453 3,577 3,544
Steroids Avoided 95 107 124 283 303 433 688 830 707 656
Rate 7.9% 7.5% 7.8% 13.8% 13.0% 16.0% 20.9% 24.0% 19.8% 18.5%
CyA+Aza Patients 109 51 56 24 52 12 5 4 6 5
Steroids Avoided 1 0 6 22 26 0 0 0 0 2
Rate 0.9% 0.0% 10.7% 91.7% 50.0% 0.0% 0.0% 0.0% 0.0% 40.0%
Tac+Aza Patients 76 65 88 100 47 21 11 19 7 38
Steroids Avoided 3 4 2 13 19 17 5 9 0 2
Rate 3.9% 6.2% 2.3% 13.0% 40.4% 81.0% 45.5% 47.4% 0.0% 5.3%
CyA+Siro Patients 36 25 25 23 23 31 42 34 28 28
Steroids Avoided 23 16 1 0 2 13 39 31 17 20
Rate 63.9% 64.0% 4.0% 0.0% 8.7% 41.9% 92.9% 91.2% 60.7% 71.4%
Tac+Siro Patients 194 197 107 54 85 50 65 26 21 13
Steroids Avoided 34 33 15 8 22 5 10 7 7 4
Rate 17.5% 16.8% 14.0% 14.8% 25.9% 10.0% 15.4% 26.9% 33.3% 30.8%
Siro+MMF Patients 28 48 46 43 42 45 42 34 37 42
Steroids Avoided 1 0 3 8 5 6 12 9 15 8
Rate 3.6% 0.0% 6.5% 18.6% 11.9% 13.3% 28.6% 26.5% 40.5% 19.0%
Other Regimen Patients 294 262 214 247 289 216 234 181 216 333
Steroids Avoided 68 55 40 66 44 44 55 57 28 38
Rate 23.1% 21.0% 18.7% 26.7% 15.2% 20.4% 23.5% 31.5% 13.0% 11.4%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive

drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;

Siro: Sirolimus.